deCode Genetics runs risk of losing stock-market listing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Related external links
DeCode Me, deCode’s personal genomics arm
deCode press release on NASDAQ letter warning of imminent delisting
Rights and permissions
About this article
Cite this article
Wadman, M. Icelandic biotech feels the pinch. Nature (2008). https://doi.org/10.1038/455842a
Published:
DOI: https://doi.org/10.1038/455842a